Long-Acting -Agonists in the Treatment of Acute Exacerbations of COPD

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.22, Iss.6, 2002-06, pp. : 369-376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-acting 2 agonists as potential option in the treatment of acute exacerbations of COPD

By Cazzola M. Matera M.G.

Pulmonary Pharmacology & Therapeutics, Vol. 16, Iss. 4, 2003-07 ,pp. : 197-201

Elsevier

Access to resources Recommend Favorite

Advances in Asthma and COPD Treatment: Combination Therapy with Inhaled Corticosteroids and Long-Acting &bgr;2-Agonists.

Current Pharmaceutical Design, Vol. 12, Iss. 25, 2006-01 ,pp. : 3261-3279

Bentham Science Publishers

Access to resources Recommend Favorite

Long-Acting Beta-Agonists and their Association with Inhaled Corticosteroids in COPD

Current Medicinal Chemistry, Vol. 20, Iss. 12, 2013-06 ,pp. : 1477-1495

Bentham Science Publishers

Access to resources Recommend Favorite

Long-acting β₂ agonists

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 1, 2006-01 ,pp. : 99-104

Informa Healthcare

Access to resources Recommend Favorite

Long-acting -agonists not linked to increased respiratory deaths

Reactions Weekly, Vol. 1, Iss. 1202, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite